Search Editorial Photos
"pharmaceutical analytics"
16 professional editorial images found
#12584429
25 July 2025
The logo and entrance of MSD (Merck Sharp & Dohme) are at the company's Berlin location in Berlin, Germany, on July 21, 2025. MSD is the international branch of American pharmaceutical giant Merck & Co., Inc., one of the world's largest biomedical companies by revenue.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12584433
25 July 2025
The logo and entrance of MSD (Merck Sharp & Dohme) are at the company's Berlin location in Berlin, Germany, on July 21, 2025. MSD is the international branch of American pharmaceutical giant Merck & Co., Inc., one of the world's largest biomedical companies by revenue.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11648398
8 October 2024
A shareholder checks the stock market with suxiao jiuxin pills (medicine for the heart) in Qingdao, China, on October 8, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11571989
14 September 2024
A worker tests diclofenac sodium injection at a pharmaceutical company in Suqian, China, on September 13, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11571993
14 September 2024
A worker tests diclofenac sodium injection at a pharmaceutical company in Suqian, China, on September 13, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11191491
29 April 2024
Technicians are checking the content of plant active ingredients on a computer at an automated production line for supercritical fluid extraction (SFE) low-temperature vacuum concentration in Zhangye, China, on April 29, 2024.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#10877986
28 December 2023
Two graduate students are researching and developing chemical products in a laboratory of a private chemical enterprise in Xiwangzhuang Town, Zaozhuang City, Shandong Province, East China, on December 26, 2023.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198012
19 November 2020
Vials in front of the Pfizer US pharmaceutical corporation logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198006
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation logo is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198008
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation logo is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198014
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198016
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198018
19 November 2020
A medical syringe in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos is seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198020
19 November 2020
A medical syringe and vials in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198010
19 November 2020
A medical syringe and a vial in front of the Pfizer US pharmaceutical corporation logo are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#6198022
19 November 2020
A medical syringe and a vial in front of the Pfizer US pharmaceutical corporation and Biontech German biotechnology company logos are seen in this creative photo taken on 18 November 2020. Pfizer and Biontech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.